Avidas Pharmaceuticals, LLC
Women's healthcare company with proprietary chemical-free technology providing optimal Vitamin D absorption while ensuring sun protection.
Avidas' focus is the science-based dermatology market integrating health with beauty. The proprietary first generation creams/lotions focus on worldwide Vitamin D deficiency (1B persons), specific target 45M US postmenopausal women. Projected revenues are over $200M. The company's bimodal transdermal delivery has broad applications (cosmetics, nutritionals and prescription-strength products) with multiple revenue opportunities.